(HAIN) The Hain Celestial - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4052171000
Stock:
Total Rating 22
Risk 32
Buy Signal -2.16
| Risk 5d forecast | |
|---|---|
| Volatility | 92.7% |
| Relative Tail Risk | -14.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.34 |
| Alpha | -94.58 |
| Character TTM | |
|---|---|
| Beta | 0.765 |
| Beta Downside | -0.240 |
| Drawdowns 3y | |
|---|---|
| Max DD | 95.74% |
| CAGR/Max DD | -0.68 |
EPS (Earnings per Share)
Revenue
Description: HAIN The Hain Celestial
The Hain Celestial Group, Inc. manufactures, markets, and sells organic and natural products in the United States, United Kingdom, Europe, and internationally. The company offers infant formula; infant and toddler formula, infant cereals, baby food pouches, snacks and frozen toddler and kids' foods; plant-based beverages such as soy, rice, oat, cashew and spelt; and condiments, as well as meat-free dishes and meals. It also provides cooking and culinary oils, vinegars, and condiments; nutritional oils and supplements; broth and soups; yogurts; desserts and creamers; and nut butters. In addition, the company offers hot-eating desserts, refrigerated and frozen meat alternative snacks and meals, vegetables and lentils, jams, fruit spreads, jellies, honey, natural sweeteners, syrups, dessert sauces, and marmalade products, as well as other food products. Further, it provides snack products comprising potato, root vegetable and other exotic vegetable chip, straw, tortilla chip; and personal care products that include hand, skin, hair, and sun care, oral care products, as well as deodorant, baby food, sunscreen, and other products under the Alba Botanica, Avalon Organics, Earth's Best, JASON, Live Clean, and Queen Helene brand name. Additionally, the company offers herbal, green, black, wellness, rooibos, and chai tea under the Celestial Seasonings brand. It sells pantry products under the Spectrum, Spectrum Essentials, MaraNatha, Imagine broth, Hain Pure Foods, and Health Valley brands. It sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and clubs, and drug and convenience stores. The company was incorporated in 1993 and is headquartered in Hoboken, New Jersey.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -543.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -3.17 > 1.0 |
| NWC/Revenue: -30.03% < 20% (prev 15.58%; Δ -45.61% < -1%) |
| CFO/TA 0.02 > 3% & CFO 30.5m > Net Income -543.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (90.7m) vs 12m ago 0.58% < -2% |
| Gross Margin: 20.02% > 18% (prev 0.22%; Δ 1980 % > 0.5%) |
| Asset Turnover: 87.59% > 50% (prev 84.84%; Δ 2.76% > 0%) |
| Interest Coverage Ratio: -8.60 > 6 (EBITDA TTM -428.2m / Interest Expense TTM 55.4m) |
Altman Z'' -4.23
| A: -0.31 (Total Current Assets 564.4m - Total Current Liabilities 1.02b) / Total Assets 1.48b |
| B: -0.06 (Retained Earnings -90.0m / Total Assets 1.48b) |
| C: -0.28 (EBIT TTM -476.5m / Avg Total Assets 1.72b) |
| D: -0.16 (Book Value of Equity -180.7m / Total Liabilities 1.15b) |
| Altman-Z'' Score: -4.23 = D |
Beneish M -3.49
| DSRI: 1.08 (Receivables 174.1m/178.3m, Revenue 1.51b/1.66b) |
| GMI: 1.11 (GM 20.02% / 22.23%) |
| AQI: 0.73 (AQ_t 0.40 / AQ_t-1 0.55) |
| SGI: 0.91 (Revenue 1.51b / 1.66b) |
| TATA: -0.39 (NI -543.8m - CFO 30.5m) / TA 1.48b) |
| Beneish M-Score: -3.49 (Cap -4..+1) = AA |
What is the price of HAIN shares?
As of February 25, 2026, the stock is trading at USD 0.78 with a total of 1,441,868 shares traded.
Over the past week, the price has changed by -12.06%, over one month by -33.71%, over three months by -28.19% and over the past year by -81.27%.
Over the past week, the price has changed by -12.06%, over one month by -33.71%, over three months by -28.19% and over the past year by -81.27%.
Is HAIN a buy, sell or hold?
The Hain Celestial has received a consensus analysts rating of 3.50.
Therefor, it is recommend to hold HAIN.
- StrongBuy: 2
- Buy: 1
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HAIN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1.6 | 103.8% |
| Analysts Target Price | 1.6 | 103.8% |
HAIN Fundamental Data Overview February 22, 2026
P/E Forward = 17.8891
P/S = 0.0516
P/B = 0.2636
P/EG = 0.8449
Revenue TTM = 1.51b USD
EBIT TTM = -476.5m USD
EBITDA TTM = -428.2m USD
Long Term Debt = 696.7m USD (from longTermDebt, last fiscal year)
Short Term Debt = 704.3m USD (from shortTermDebt, last quarter)
Debt = 766.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 698.0m USD (from netDebt column, last quarter)
Enterprise Value = 775.7m USD (77.7m + Debt 766.0m - CCE 68.0m)
Interest Coverage Ratio = -8.60 (Ebit TTM -476.5m / Interest Expense TTM 55.4m)
EV/FCF = 151.4x (Enterprise Value 775.7m / FCF TTM 5.12m)
FCF Yield = 0.66% (FCF TTM 5.12m / Enterprise Value 775.7m)
FCF Margin = 0.34% (FCF TTM 5.12m / Revenue TTM 1.51b)
Net Margin = -36.12% (Net Income TTM -543.8m / Revenue TTM 1.51b)
Gross Margin = 20.02% ((Revenue TTM 1.51b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = 19.38% (prev 18.51%)
Tobins Q-Ratio = 0.53 (Enterprise Value 775.7m / Total Assets 1.48b)
Interest Expense / Debt = 2.04% (Interest Expense 15.7m / Debt 766.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -376.5m (EBIT -476.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.56 (Total Current Assets 564.4m / Total Current Liabilities 1.02b)
Debt / Equity = 2.32 (Debt 766.0m / totalStockholderEquity, last quarter 330.2m)
Debt / EBITDA = -1.63 (negative EBITDA) (Net Debt 698.0m / EBITDA -428.2m)
Debt / FCF = 136.2 (Net Debt 698.0m / FCF TTM 5.12m)
Total Stockholder Equity = 486.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -31.64% (Net Income -543.8m / Total Assets 1.48b)
RoE = -111.7% (Net Income TTM -543.8m / Total Stockholder Equity 486.7m)
RoCE = -40.27% (EBIT -476.5m / Capital Employed (Equity 486.7m + L.T.Debt 696.7m))
RoIC = -31.51% (negative operating profit) (NOPAT -376.5m / Invested Capital 1.19b)
WACC = 2.27% (E(77.7m)/V(843.7m) * Re(8.73%) + D(766.0m)/V(843.7m) * Rd(2.04%) * (1-Tc(0.21)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.47%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈30.6m ; Y1≈20.1m ; Y5≈9.18m
Fair Price DCF = N/A (negative equity: EV 292.4m - Net Debt 698.0m = -405.5m; debt exceeds intrinsic value)
EPS Correlation: -68.93 | EPS CAGR: -40.94% | SUE: -0.55 | # QB: 0
Revenue Correlation: -91.30 | Revenue CAGR: -6.93% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.02 | Chg30d=-0.089 | Revisions Net=-3 | Analysts=5
EPS current Year (2026-06-30): EPS=-0.14 | Chg30d=-0.157 | Revisions Net=-3 | Growth EPS=-255.8% | Growth Revenue=-11.6%
EPS next Year (2027-06-30): EPS=0.19 | Chg30d=-0.010 | Revisions Net=-2 | Growth EPS=+232.7% | Growth Revenue=-3.0%
P/S = 0.0516
P/B = 0.2636
P/EG = 0.8449
Revenue TTM = 1.51b USD
EBIT TTM = -476.5m USD
EBITDA TTM = -428.2m USD
Long Term Debt = 696.7m USD (from longTermDebt, last fiscal year)
Short Term Debt = 704.3m USD (from shortTermDebt, last quarter)
Debt = 766.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 698.0m USD (from netDebt column, last quarter)
Enterprise Value = 775.7m USD (77.7m + Debt 766.0m - CCE 68.0m)
Interest Coverage Ratio = -8.60 (Ebit TTM -476.5m / Interest Expense TTM 55.4m)
EV/FCF = 151.4x (Enterprise Value 775.7m / FCF TTM 5.12m)
FCF Yield = 0.66% (FCF TTM 5.12m / Enterprise Value 775.7m)
FCF Margin = 0.34% (FCF TTM 5.12m / Revenue TTM 1.51b)
Net Margin = -36.12% (Net Income TTM -543.8m / Revenue TTM 1.51b)
Gross Margin = 20.02% ((Revenue TTM 1.51b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = 19.38% (prev 18.51%)
Tobins Q-Ratio = 0.53 (Enterprise Value 775.7m / Total Assets 1.48b)
Interest Expense / Debt = 2.04% (Interest Expense 15.7m / Debt 766.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -376.5m (EBIT -476.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.56 (Total Current Assets 564.4m / Total Current Liabilities 1.02b)
Debt / Equity = 2.32 (Debt 766.0m / totalStockholderEquity, last quarter 330.2m)
Debt / EBITDA = -1.63 (negative EBITDA) (Net Debt 698.0m / EBITDA -428.2m)
Debt / FCF = 136.2 (Net Debt 698.0m / FCF TTM 5.12m)
Total Stockholder Equity = 486.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -31.64% (Net Income -543.8m / Total Assets 1.48b)
RoE = -111.7% (Net Income TTM -543.8m / Total Stockholder Equity 486.7m)
RoCE = -40.27% (EBIT -476.5m / Capital Employed (Equity 486.7m + L.T.Debt 696.7m))
RoIC = -31.51% (negative operating profit) (NOPAT -376.5m / Invested Capital 1.19b)
WACC = 2.27% (E(77.7m)/V(843.7m) * Re(8.73%) + D(766.0m)/V(843.7m) * Rd(2.04%) * (1-Tc(0.21)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.47%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈30.6m ; Y1≈20.1m ; Y5≈9.18m
Fair Price DCF = N/A (negative equity: EV 292.4m - Net Debt 698.0m = -405.5m; debt exceeds intrinsic value)
EPS Correlation: -68.93 | EPS CAGR: -40.94% | SUE: -0.55 | # QB: 0
Revenue Correlation: -91.30 | Revenue CAGR: -6.93% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.02 | Chg30d=-0.089 | Revisions Net=-3 | Analysts=5
EPS current Year (2026-06-30): EPS=-0.14 | Chg30d=-0.157 | Revisions Net=-3 | Growth EPS=-255.8% | Growth Revenue=-11.6%
EPS next Year (2027-06-30): EPS=0.19 | Chg30d=-0.010 | Revisions Net=-2 | Growth EPS=+232.7% | Growth Revenue=-3.0%